Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0035802 METHOD FOR TREATING ITCHING
The present invention relates to an anti-itching agent that prevents itch of skin and a method for treating itching. An emulsion, which is produced when sebum...
2017/0035800 Reduction of Oxalate Absorption in Individuals
In various implementations, an oxalate absorption blocking (OAB) composition may be administered to improve a health of an individual. The OAB composition may...
2017/0035799 COMBINATION OF GLYCOSAMINOGLYCANS AND CYCLODEXTRINS
The invention relates to an injectable combination of two specific glycosaminoglycans, hyaluronic acid and chondroitin sulfate, with cyclodextrins and the use...
2017/0035798 MODULATION OF FACTOR 11 EXPRESSION
Disclosed herein are antisense compounds and methods for decreasing Factor 11 and treating or preventing thromboembolic complications in an individual in need...
2017/0035796 RNAi Therapy for Hepatitis B Virus Infection
Described are compositions and methods for inhibition of Hepatitis B virus gene expression. RNA interference (RNAi) triggers and RNAi trigger conjugates for...
2017/0035794 Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein
Oligonucleotide analogues are provided that incorporate 5-aza-cytosine in the oligonucleotide sequence, e.g., in the form of 5-aza-2'-deoxycytidine ...
2017/0035791 COMBINATION OF BETA-GLUCOSYLCERAMIDE AND POLYETHOXYLATED CASTOR OIL AND OTHER ADJUVANTS FOR CONTROLING BLOOD...
The disclosure relates to compositions and methods for adding beta glucosylceramide and/or Cremophor EL (CE), or an adjuvant selected from polyethylene glycol...
2017/0035787 Fixed Dose Combination for Pain Relief Without Edema
Compositions and methods for individualized therapy of pain using a non-steroidal anti-inflammatory drug (NSAID) and an anti-hypertensive without inducing...
2017/0035785 Compositions and Methods for the Treatment of Meibomian Gland Dysfunction
Described herein are compositions and methods for the treatment of meibomian gland dysfunction. Said compositions and methods comprise keratolytic agents, such...
2017/0035784 COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
The disclosure relates to obeticholic acid formulations with improved stability, dissolution, and/or solubility, methods of preparing the same for use and...
2017/0035783 COMPOSITION FOR THE PREVENTION AND THERAPY OF TUMOR DISEASES
The invention relates to a means of prevention and therapy of hormone-sensitive tumour tissue, especially for the prevention and/or inhibition of mammary...
2017/0035781 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODS
The present invention provides for bioavailable oral dosage forms containing esters of 17-hydroxyprogesterone as well as related methods. The oral dosage forms...
2017/0035780 Combination of Azelastine and Fluticasone for Nasal Administration
A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative...
2017/0035779 TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH
Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or...
2017/0035778 FORMULATIONS AND USES FOR MICROPARTICLE DELIVERY OF METALLOPORPHYRINS
Formulations and methods of use thereof that relate to biocompatible delivery of stabilized porphyrin complexes are provided. Formulations may include...
2017/0035774 APREPITANT ORAL LIQUID FORMULATIONS
A liquid pharmaceutical compositions comprising Aprepitant is preferably prepared as an oral suspension dosage form for the prevention and control of acute and...
2017/0035773 PREPARATION CONTAINING TETRACYCLIC COMPOUND AT HIGH DOSE
An improved solubility of a pharmaceutical composition or formulation containing a large amount of ...
2017/0035770 TREATMENT OF ERECTILE DYSFUNCTION AND OTHER INDICATIONS
The present invention generally relates to the transdermal delivery of various compounds. In some aspects, transdermal delivery may be facilitated by the use...
2017/0035769 NOVEL PYRAZOL DERIVATIVES
The invention relates to a compound of formula (I) ##STR00001## wherein A.sup.1 to A.sup.3 and R.sup.1 to R.sup.3 are defined as in the description and in the...
2017/0035766 IRAK INHIBITORS AND USES THEREOF
The present invention provides compounds, compositions thereof, and methods of using the same.
2017/0035762 USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
Disclosed herein are methods for treating a cancer comprising: a. administering a Btk inhibitor to a subject sufficient to result in an increase or appearance...
2017/0035755 SYK INHIBITORS
The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and...
2017/0035750 NEW ANTI-CLOSTRIDIUM COMPOUNDS
The present invention relates to compounds having a backbone structure for use as antibiotic, more specifically use against infections with Gram positive...
2017/0035746 Pancreatic Cancer Therapy and Diagnosis
The present invention provides novel cancer therapeutics for treating pancreatic cancer, and novel diagnostic methods for detecting chronic pancreatitis and...
2017/0035742 DURABLE TREATMENT WITH 4-AMINOPYRIDINE IN PATIENTS WITH DEMYELINATION
Disclosed herein are methods and compositions related to the durable use of aminopyridines, such as 4-aminopyridine, to improve impairments of patients with a...
2017/0035736 Compositions and Methods Comprising a Compounded Composition
The present application relates to compounded compositions, methods of making compounded compositions, kits comprising compounded compositions, containers...
2017/0035735 Use Of Enoximone In The Treatment Of Atopic Immune-Related Disorders, In Pharmaceutical Composition As Well As...
The invention involves the use of compounds from the class of aroyl-2H-imidazol-2-ones such as enoximone or a pharmaceutically acceptable salt thereof for...
2017/0035730 PPARG MODULATORS FOR TREATMENT OF OSTEOPOROSIS
The invention provides methods of treatment of a progressive bone disease, such as osteoporosis, Paget's Disease, multiple myeloma, or hyperparathyroidism,...
2017/0035729 PHARMACEUTICAL COMPOSITION FOR TREATING MIGRAINE
The present application relates to a method of treating migraine or cluster headache in a human patient, said method comprising administering subcutaneously...
2017/0035728 Compositions for Improved Body Composition
A nutritional supplement is provided comprising alpha-lipoic acid and curcumin. The nutritional supplement may be used for reducing weight or reducing weight...
2017/0035727 TREATMENT OR PREVENTION OF SEBORRHEIC KERATOSIS USING ARTEMISININ AND DERIVATIVES THEREOF
The invention relates to a method of treating or preventing seborrheic keratosis. The method comprises locally applying to a subject in need thereof...
2017/0035721 COMPOSITION FOR PREVENTING OR IMPROVING PERIPHERAL NEUROPATHY
Compositions which contain an amino acid containing serine and a lipid containing a n-3 fatty acid are useful for the prophylaxis or improvement of peripheral...
2017/0035720 Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments
Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the...
2017/0035719 EICOSAPENTAENOIC ACID (EPA) FORMULATIONS
Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any...
2017/0035716 METHOD OF USING SOLABEGRON
Pharmaceutical combinations comprising a beta-3 adrenergic receptor agonist and a muscarinic receptor antagonist, and methods for their use are disclosed....
2017/0035715 TOPICAL ANALGESIC LOTION
Technologies are described for a formulation and production of a formulation. The methods may comprise depositing a non-steroidal anti-inflammatory drug...
2017/0035714 Oral Dosage forms having a High Loading of a Gabapentin Prodrug
Sustained release oral dosage forms with a high loading of a gabapentin prodrug are disclosed.
2017/0035713 SYNERGISTIC COMBINATIONS OF CAROTENOIDS AND POLYPHENOLS
The present invention provides a therapeutic composition comprising one or more polyphenols and one or more carotenoids selected from the group consisting of...
2017/0035712 DOPAMINERGIC MIMETICS
A method is described for providing acute symptomatic relief to a subject with Parkinson's Disease (PD) or other CNS disorders resulting from dopamine...
2017/0035711 PARASITE CONTROL AGENT FOR PARASITICIDE
A parasite-control or parasiticide agent that exhibits excellent effects of controlling or expelling parasites, particularly endoparasites and that can be used...
2017/0035709 METHODS OF TREATING PAIN OR FEVER USING PHARMACEUTICALLY ACTIVE ACETAMINOPHEN DIMERS LINKED THROUGH PHENOLIC...
Provided herein are methods for treating pain such as acute or chronic pain or fever in subject without risking hepatotoxicity. The subject may be at risk of...
2017/0035708 USE OF N-(4-TERT-BUTYLBENZYL)-3-CHLORO-N-[2-(4-CHLORO-3-ETHYL-PHENYL)-ETHY- ...
The present invention relates N-(4-tert-Butyl-benzyl)-3-chloro-N-[2-(4-chloro-3-ethyl-phenyl)-ethyl]-2-- fluoro-5-trifluoromethyl-benz-amide which is useful in...
2017/0035706 DETRUSOR HYPERACTIVITY WITH IMPAIRED CONTRACTILITY AMELIORATING AGENT
Problem to Be Solved by the Invention: To providing a method for ameliorating DHIC. Means for Solving the Problem: This invention is directed to a treating ...
2017/0035705 DETRUSOR HYPERACTIVITY WITH IMPAIRED CONTRACTILITY AMELIORATING AGENT
Problem to Be Solved by the Invention: To providing a method for ameliorating DHIC. Means for Solving the Problem: This invention is directed to a treating method for...
2017/0035704 Composition for the Transdermal Delivery of Fentanyl
A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery...
2017/0035703 Method of Treating Adhesion by Altering an Epithelial to Mesenchymal Transition
The present invention is a method of treating adhesion including the prevention or reduction of abdominal, pelvic, and thoracic adhesions, by administering an...
2017/0035701 STABILIZED HIGH DRUG LOAD NANOCARRIERS, METHODS FOR THEIR PREPARATION AND USE THEREOF
The present invention relates to generally to pharmaceutical formulations. Particularly, the present invention relates to a drug nanocarrier that is stabilized...
2017/0035698 DELAYED RELEASE DRUG FORMULATION
In a delayed release formulation comprising a core containing a drug and a delayed release coating for providing intestinal release, release of the drug in the...
2017/0035697 IMMEDIATE RELEASE FILM COATINGS CONTAINING MEDIUM CHAIN GLYCERIDES AND SUBSTRATES COATED THEREWITH
The present invention is directed to immediate release film coating compositions for use on oral dosage forms such as compressed tablets and other...
2017/0035696 Composition of analgesic bioadhesive healing microspheres
A new composition of analgesic bioadhesive healing microspheres in which each microsphere comprises at least: a.--a layer of a polyanion, where the polyanion may...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.